| | The United States has administered 339,763,765 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 391,998,625 doses, the U.S. Centers for Disease Control and Prevention said on Thursday. | | | The U.S. Food and Drug Administration on Thursday classified the recall of Philips' (PHG.AS) breathing devices and ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death. | | | The Italian government, looking to contain a fresh surge in coronavirus cases, announced on Thursday that from next month people must present proof of immunity to access an array of services and leisure activities. | | | Two Democratic U.S. senators on Thursday will add to the stack of bills going after Section 230 - a law that protects tech companies from being sued over content posted by users - making such platforms responsible for health-related misinformation. | | | Chile announced on Thursday that its citizens and foreign residents would be allowed to travel outside the country if they are fully inoculated against coronavirus, a fresh perk for Chileans participating in one of the world's fastest vaccination campaigns. | | | Advisers to the U.S. Centers for Disease Control and Prevention on Thursday will consider evidence suggesting that a booster dose of COVID-19 vaccines could increase protection among people with compromised immune systems. | | | German pharmacies have stopped issuing digital COVID-19 vaccination certificates after hackers created passes from fake outlets, the industry association said on Thursday, the latest blow to the inoculation drive. | | | Argentina, one of the first countries to widely use Russia's Sputnik V COVID-19 vaccine, has ratcheted up pressure on Moscow over delays in the arrival of second doses that are holding back the South American nation's inoculation campaign. | | | The White House said on Thursday it is "deeply disappointed" in China's decision to reject a World Health Organization (WHO) plan for a second phase of an investigation into the origin of the coronavirus. | | | U.S. hospitals that were expected to be early adopters of Biogen's (BIIB.O) Alzheimer's drug have treated only a handful of patients since its early June approval as they wait for the first payments from the government's Medicare program for people aged 65 and older. | | | | |